Balovaptan

N/A

Report date: 2026/02/04 10:22:36
NME

Base Information

Drug NameBalovaptan
Drug Alias NameRG-7314RO-5285119
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor antagonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsIschemic StrokeStress Disorders, Post-TraumaticAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStress Disorders, Post-Traumatic
Inactive IndicationsAutism Spectrum Disorder

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG